Arrowhead Pharmaceuticals (UK) Today
| 0HI3 Stock | 18.63 0.04 0.22% |
Performance0 of 100
| Odds Of DistressOver 65
|
Arrowhead Pharmaceuticals is selling for under 18.63 as of the 21st of November 2024; that is 0.22% up since the beginning of the trading day. The stock's lowest day price was 18.25. Arrowhead Pharmaceuticals has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Arrowhead Pharmaceuticals Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of December 2022 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
Arrowhead Pharmaceuticals is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 88.02 M outstanding shares. More on Arrowhead Pharmaceuticals Corp
Arrowhead Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arrowhead Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arrowhead Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Christopher Anzalone | ||||
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) | ||||
Arrowhead Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Arrowhead Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Arrowhead Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Arrowhead Pharmaceuticals' financial leverage. It provides some insight into what part of Arrowhead Pharmaceuticals' total assets is financed by creditors.
| |||||
Arrowhead Pharmaceuticals Corp (0HI3) is traded on London Exchange in UK and employs 525 people. Arrowhead Pharmaceuticals is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 182.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arrowhead Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Arrowhead Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arrowhead Pharmaceuticals operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 88.02 M outstanding shares.
Arrowhead Pharmaceuticals generates negative cash flow from operations
Check Arrowhead Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationArrowhead Pharmaceuticals holds a total of 88.02 Million outstanding shares. The majority of Arrowhead Pharmaceuticals Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Arrowhead Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Arrowhead Pharmaceuticals. Please pay attention to any change in the institutional holdings of Arrowhead Pharmaceuticals Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arrowhead Ownership Details
Arrowhead Pharmaceuticals Risk Profiles
Although Arrowhead Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Arrowhead Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.37 | |||
| Standard Deviation | 3.12 | |||
| Variance | 9.72 | |||
| Risk Adjusted Performance | (0.06) |
Arrowhead Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arrowhead Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Arrowhead Pharmaceuticals Corporate Management
Elected by the shareholders, the Arrowhead Pharmaceuticals' board of directors comprises two types of representatives: Arrowhead Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arrowhead. The board's role is to monitor Arrowhead Pharmaceuticals' management team and ensure that shareholders' interests are well served. Arrowhead Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arrowhead Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vincent CFA | Head VP | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Kenneth Myszkowski | Chief Officer | Profile | |
| Javier MD | Chief Officer | Profile | |
| Bruce MD | Chief Scientist | Profile | |
| MBA MD | Chief Medicine | Profile | |
| Tracie Oliver | Chief Officer | Profile |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.